InsidersTradesSigma
Genovis AB: insider trades · Finland · FIN-FSA
FI:genovis-abSE0002485979FI·FIN-FSAMcap 1.4Bn€Healthcare & Pharma
Discover the full insider trade history of Genovis AB, a listed equity based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare & Pharma sector, Genovis AB has recorded 6 reports. Market capitalisation: €1.4bn. The latest transaction was reported on 15 May 2026 — Purchase. Among the most active insiders: Fredrik Olsson. The full history is openly available.
6
Insider Decl.
0
Thresholds
€54,455
4 ops.
Buy Volume
€1m
2 ops.
Sell Volume
Financial data
20.65 €
Analyst consensus
3 analystsStrong buy
27.00 €Target 32.67 €(+58%)41.00 €
Valuation
PER (trailing)55.8x
PER (forward)33.3x
P/Book4.9x
Beta1.70
Balance sheet & cash
Market cap1.36 Bn€
Debt / Equity26%
Profitability & ownership
ROE9.5%
ROA4.2%
% insiders18.2%
% institutions36.1%
Last declaration on 15 May 2026
Declarations6 total
Executives●Purchase11FIN-FSA
SEK 6,9244,146 shares@ SEK 1.67100.0% of flow
Aktie
FI:A003Y639-1·
Ideal exit: 9 Feb 2027 (T+270)
Executives●Purchase32FIN-FSA
€3,9262,470 shares@ €1.58930.0003% mcap100.0% of flow
Aktie
FI:A003W421-1·
Ideal exit: 21 Nov 2026 (T+270)
Executives●Purchase32FIN-FSA
€21,27313,000 shares@ €1.63640.0016% mcap48.8% of flow
Aktie
FI:A003W055-1·
Ideal exit: 13 Nov 2026 (T+270)
Executives●Sale22FIN-FSA
€599,306255,653 shares@ €2.34420.044% mcap52.5% of flow
Aktie
FI:A003O854-1·
Executives●Sale21FIN-FSA
€541,392235,000 shares@ €2.30380.040% mcap47.5% of flow
Aktie
FI:A003M263-1·
Executives●Purchase32FIN-FSA
€22,33310,418 shares@ €2.14360.0016% mcap51.2% of flow
Aktie
FI:A003M248-1·
Ideal exit: 1 Dec 2025 (T+270)
6 of 6 declarations
